IL-10 elicits IFNγ-dependent tumor immune surveillance.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Cancer Cell

• Publication date

  2011-12-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ccr.2011.11.003PMID 22172723
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Emerging concepts in CD8(+) T regulatory cells.

  2008cited by this paper
• Equilibrium between host and cancer caused by effector T cells killing tumor stroma.

  2008cited by this paper
• Epitope landscape in breast and colorectal cancer.

  2008cited by this paper
• Strategies for use of IL‐10 or its antagonists in human disease

  2008cited by this paper
• Cytokine-based transformation of immune surveillance into tumor-promoting inflammation

  2008cited by this paper
• Interleukin-10 production by effector T cells: Th1 cells show self control

  2007cited by this paper
• TH1 cells control themselves by producing interleukin-10

  2007cited by this paper
• The Genomic Landscapes of Human Breast and Colorectal Cancers

  2007cited by this paper
• Swords into plowshares: IL-23 repurposes tumor immune surveillance.

  2007cited by this paper
• Understanding the IL-23-IL-17 immune pathway.

  2006cited by this paper
• IL-23 promotes tumour incidence and growth

  2006influential reference
• Interleukin-10 determines viral clearance or persistence in vivo

  2006cited by this paper
• Tumour necrosis factor-α as a tumour promoter

  2006cited by this paper
• Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

  2006influential reference
• Tumour necrosis factor-alpha as a tumour promoter.

  2006cited by this paper
• Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M.

  2006cited by this paper
• Interferons, immunity and cancer immunoediting

  2006cited by this paper
• Tumor Progression Can Occur despite the Induction of Very High Levels of Self/Tumor Antigen-Specific CD8+ T Cells in Patients with Melanoma

  2005cited by this paper
• Priming in the Presence of IL-10 Results in Direct Enhancement of CD8+ T Cell Primary Responses and Inhibition of Secondary Responses1

  2005cited by this paper
• Smoldering and polarized inflammation in the initiation and promotion of malignant disease.

  2005cited by this paper
• Cancer: An inflammatory link

  2004cited by this paper
• Antigen‐specific immunotherapy and cancer vaccines

  2003cited by this paper
• Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes

  2002cited by this paper
• Tumor‐specific shared antigenic peptides recognized by human T cells

  2002cited by this paper
• Reversal of Tumor-induced Dendritic Cell Paralysis by CpG Immunostimulatory Oligonucleotide and Anti–Interleukin 10 Receptor Antibody

  2002cited by this paper
• HLA class I antigen abnormalities and immune escape by malignant cells.

  2002influential reference
• Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon γ

  2002cited by this paper
• Interleukin-10 promotes the maintenance of antitumor CD8(+) T-cell effector function in situ.

  2001influential reference
• Interleukin-10 and the interleukin-10 receptor.

  2001influential reference
• Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells.

  2001cited by this paper
• Proinflammatory Effects of IL-10 During Human Endotoxemia1

  2000cited by this paper
• Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

  1999cited by this paper
• Transgenic Interleukin 10 Prevents Induction of Experimental Autoimmune Encephalomyelitis

  1999cited by this paper
• A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells.

  1999cited by this paper
• IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense.

  1999cited by this paper
• Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells.

  1998cited by this paper
• CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.

  1998cited by this paper
• Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration.

  1997cited by this paper
• IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia.

  1997cited by this paper
• Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism

  1996cited by this paper
• Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice.

  1996cited by this paper
• IL-10: a novel cytotoxic T cell differentiation factor.

  1991cited by this paper
• T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures.

  1984cited by this paper
• lnterleukin-10-Deficient Mice Develop Chronic Enterocolitis

  year unknowncited by this paper

• “Cytokine-Mediated tumor sensitization: mechanistic frameworks and therapeutic opportunities in cancer Immunotherapy”

  2026cites this paper
• Beyond suppression: the paradox of JAK inhibitors as amplifiers of cancer immunotherapy.

  2026cites this paper
• Co-delivery of IL-12/IL-15/IL-18 engineered DC vaccines with anti-IL-10R and nanoconjugated methotrexate in melanoma

  2026cites this paper
• Integrated single-cell and transcriptomic analysis of CD8+CD101+TIM3+ T cells in hepatocellular carcinoma: implications for tumor microenvironment and prognostic modeling

  2026cites this paper
• Targeting immune cells in the aged brain reveals that engineered cytokine IL-10 enhances neurogenesis and improves cognition.

  2026cites this paper
• Inflame and restrain - the paradoxical roles of IL-12 and IL-23 in immunity.

  2026cites this paper
• Rewiring STAT signaling from the cell surface with Trikine immunotherapeutics.

  2026cites this paper
• Alterations of gastric fluid microbiota in patients with gastric cancer

  2026cites this paper
• Adjusting the scope of natural killer cells in cancer therapy

  2025cites this paper
• Tumor-derived small extracellular vesicles loaded with functionally active miR-34a mimic can modify the anti-tumor response in 4T1 breast cancer animal model

  2025cites this paper
• IL-10-Directed Cancer Immunotherapy: Preclinical Advances, Clinical Insights, and Future Perspectives

  2025cites this paper
• The immunomodulatory role of human cytomegalovirus in cancer in the era of checkpoint immunotherapy

  2025cites this paper
• Crossroads between autoimmunity and cancer: Underlying mechanisms and clinical implications.

  2025cites this paper
• Cytokine-driven cancer immune evasion mechanisms.

  2025cites this paper
• Structural conservation and functional adaptation of porcine interleukin-10: evolutionary insights and viral mimicry.

  2025cites this paper
• An inulin-type fructan CP-A from Codonopsis pilosula combined with 5-Fluorouracil alleviates colitis-associated tumorigenesis via inhibition of EGFR/AKT/ERK signaling pathway and regulation of intestinal flora.

  2025cites this paper
• Virus nanoparticle intratumoral vaccines for HER2+ malignancies

  2025cites this paper
• Interferon-γ and IL-27 positively regulate type 1 regulatory T cell development during adaptive tolerance

  2025cites this paper
• Structural design of IL10 to obtain more effective drugs with lower affinity against IL10Rb and decoupled pro- and anti-inflammatory functions

  2025cites this paper
• Lymphocytes and monocytes undergo swift suppression of IL-10R, IL-6R, and IL-2Rβγ signaling under high concentrations of different cytokines

  2025cites this paper
• Single-Cell Multiomics Reveals Regulatory Mechanisms of CAR T Cell Persistence and Dysfunction in Multiple Myeloma

  2025cites this paper
• IL-10 from tumoral B cells modulates the diffuse large B-cell lymphoma microenvironment and response to immunotherapy

  2025cites this paper
• Coupling IL-2 with IL-10 to mitigate toxicity and enhance antitumor immunity

  2025cites this paper
• Increased protein expression of interleukin-10 and its signalling molecules in colon cancer progression: potential prognostic and therapeutic targets

  2025cites this paper
• Radical hemithorax radiotherapy induces an increase in circulating PD-1+ T lymphocytes and in the soluble levels of PD-L1 in malignant pleural mesothelioma patients: a possible synergy with PD-1/PD-L1 targeting treatment?

  2025cites this paper
• Peroxiredoxin 1 Promotes Proinflammatory Cytokine Secretion in Human Dysplastic Oral Keratinocytes and Mouse Tongue Precancerous Tissues

  2025cites this paper
• Unmasking immune checkpoint resistance in esophageal squamous cell carcinoma: Insights into the tumor microenvironment and biomarker landscape

  2025cites this paper
• Interleukin 10: Bridging the chasms in the immune landscape of multiple myeloma.

  2025cites this paper
• The next innovations in chimeric antigen receptor T cell immunotherapies for cancer.

  2025cites this paper
• The multifaceted roles of macrophages in the transition from hepatitis to hepatocellular carcinoma: From mechanisms to therapeutic strategies.

  2025cites this paper
• Regulators of CD8+ T cell exhaustion

  2025cites this paper
• SARS-CoV-2 Infection Alters the Immune Microenvironment in Lung Cancer Patients Undergoing Immunotherapy and Affects Treatment Outcomes

  2025cites this paper
• Crosstalk Between Cancer‐Associated Fibroblasts and Immune Cells: Mechanisms and Therapeutic Implications

  2025cites this paper
• Causal relationships between immune cells and common urinary system tumors: A bidirectional analysis of Mendelian randomization

  2025cites this paper
• An innovative engineered IL-10 monomer strengthens T cell-mediated anti-tumor responses through anti-PD-1 cis-delivery

  2025cites this paper
• Association of Immune Cells, Inflammatory Cytokines, and Lung Cancer: A Mediating Mendelian Randomization Study

  2025cites this paper
• Inflammatory biomarkers to predict clinical outcomes in adults after cardiac surgery in China: a prospective observational trial.

  2025cites this paper
• Multimodal cell-cell communication driving CD8+ T cell dysfunction and immune evasion

  2025cites this paper
• Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization.

  2025cites this paper
• The multifaceted landscape of T cell exhaustion in organ transplantation: From molecular mechanisms (epigenetics, transcription, metabolism) to induction strategies

  2025cites this paper
• Targeting T cell exhaustion: emerging strategies in non-small cell lung cancer

  2024cites this paper
• The Role of Selected Interleukins in the Development and Progression of Multiple Sclerosis—A Systematic Review

  2024cites this paper
• Long-term survival after local immunotherapy for malignant gliomas: a retrospective study with 20 years follow-up

  2024cites this paper
• Uterine Commensal Peptostreptococcus Species Contribute to IDO1 Induction in Endometrial Cancer via Indoleacrylic Acid

  2024cites this paper
• Preconditioning with Wound Fluid Enhances Immunosuppressive Properties of Mesenchymal Stromal Cells In Vitro

  2024cites this paper
• Lung Transplant Immunomodulation with Genetically Engineered Mesenchymal Stromal Cells—Therapeutic Window for Interleukin-10

  2024cites this paper
• Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review

  2024cites this paper
• Unlocking the dual role of LSD1 in tumor immunity: innate and adaptive pathways

  2024cites this paper
• Hypothetical proteins of chicken-isolated Limosilactobacillus reuteri subjected to in silico analyses induce IL-2 and IL-10

  2024cites this paper
• Epigenetic tuning of tumour-associated macrophages (TAMs): a potential approach in hepatocellular carcinoma (HCC) immunotherapy

  2024cites this paper
• Interleukins: Role in cancer and its immunotherapy

  2024cites this paper
• Regulation of inflammation by Interleukin-10 in the intestinal and respiratory mucosa.

  2024cites this paper
• Systems profiling reveals recurrently dysregulated cytokine signaling responses in ER+ breast cancer patients’ blood

  2024cites this paper
• The molecular landscape of T cell exhaustion in the tumor microenvironment and reinvigoration strategies

  2024cites this paper
• The hallmarks of cancer immune evasion.

  2024cites this paper
• Investigating the complex interplay between fibroblast activation protein α-positive cancer associated fibroblasts and the tumor microenvironment in the context of cancer immunotherapy

  2024cites this paper
• Interferon-γ and IL-27 positively regulate type 1 regulatory T-cell development during adaptive tolerance

  2024cites this paper
• Complex Role of Regulatory T Cells (Tregs) in the Tumor Microenvironment: Their Molecular Mechanisms and Bidirectional Effects on Cancer Progression

  2024cites this paper
• Targeting inflammation as cancer therapy

  2024cites this paper
• Review of dietary patterns and gastric cancer risk: epidemiology and biological evidence

  2024cites this paper
• Immunometabolism of CD8+ T cell differentiation in cancer.

  2024cites this paper
• Exploring the role of the immune microenvironment in hepatocellular carcinoma: Implications for immunotherapy and drug resistance

  2024cites this paper
• The Mechanisms of Altered Blood–Brain Barrier Permeability in CD19 CAR T–Cell Recipients

  2024cites this paper
• Interleukin-10 deficiency suppresses colorectal cancer metastasis by enriching gut Parabacteroides distasonis

  2024cites this paper
• Macrophage Colony Stimulating Factor (M-CSF) and Interleukin-34 (IL-34) Expression in Canine Osteosarcoma in the Context of the Tumour Immune Microenvironment.

  2024cites this paper
• Injectable Granular Hydrogels Enable Avidity-Controlled Biotherapeutic Delivery

  2024cites this paper
• Invention and characterization of a systemically administered, attenuated and killed bacteria-based multiple immune receptor agonist for anti-tumor immunotherapy

  2024cites this paper
• The pleiotropic CLEC10A: implications for harnessing this receptor in the tumor microenvironment

  2024cites this paper
• A dual-role for IL-10: From leukemogenesis to the tumor progression in acute lymphoblastic leukemia.

  2023cites this paper
• A CSF-1R-blocking antibody/IL-10 fusion protein increases anti-tumor immunity by effectuating tumor-resident CD8+ T cells

  2023cites this paper
• The role of interferon-gamma and its receptors in gastrointestinal cancers.

  2023cites this paper
• Engineering cytokines for cancer immunotherapy: a systematic review

  2023cites this paper
• The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions

  2023cites this paper
• Metastatic lymph node targeted CTLA4 blockade: a potent intervention for local and distant metastases with minimal ICI-induced pneumonia

  2023cites this paper
• Exercise training induces alteration of clock genes and myokines expression in tumor‐bearing mice

  2023cites this paper
• Emerging interleukin targets in the tumour microenvironment: implications for the treatment of gastrointestinal tumours

  2023cites this paper
• Interleukin-10 in cancer immunotherapy: from bench to bedside.

  2023cites this paper
• Early Detection of Therapeutic Benefit from PD-1/PD-L1 Blockade in Advanced Lung Cancer by Monitoring Cachexia-Related Circulating Cytokines

  2023cites this paper
• Breast cancer progression and kynurenine pathway enzymes are induced by hexachlorobenzene exposure in a Her2-positive model.

  2023cites this paper
• Recent advances in long-acting drug delivery systems for anticancer drug.

  2023cites this paper
• IL-10 production by granulocytes promotes Staphylococcus aureus craniotomy infection

  2023cites this paper
• Activated Chicken Gamma Delta T Cells Are Involved in Protective Immunity against Marek’s Disease

  2023cites this paper
• Istradefylline induces A2A/P2X7 crosstalk expression inducing pro-inflammatory signal, and reduces AKT/mTOR signaling in melanoma-bearing mice

  2023cites this paper
• IL-10 dampens antitumor immunity and promotes liver metastasis via PD-L1 induction

  2023cites this paper
• A peptide derived from interleukin-10 exhibits potential anticancer activity and can facilitate cell targeting of gold nanoparticles loaded with anticancer therapeutics

  2023cites this paper
• Efficacy and tolerability of an mRNA vaccine expressing gB and pp38 antigens of Marek's disease virus in chickens.

  2023cites this paper
• The Anti-Cancer Activity of the Naturally Occurring Dipeptide Carnosine: Potential for Breast Cancer

  2023cites this paper
• Systems profiling reveals recurrently dysregulated cytokine signaling responses in ER+ breast cancer patients’ blood

  2023cites this paper
• Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7)

  2023cites this paper
• Single-cell RNA-seq analyses inform necroptosis-associated myeloid lineages influence the immune landscape of pancreas cancer

  2023cites this paper
• Review of Current Systemic Therapy and Novel Systemic Therapy for Pancreatic Ductal Adenocarcinoma

  2023cites this paper
• Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases

  2022cites this paper
• LyeTxI-b, a Synthetic Peptide Derived From a Spider Venom, Is Highly Active in Triple-Negative Breast Cancer Cells and Acts Synergistically With Cisplatin

  2022cites this paper
• Saga of monokines in shaping tumour-immune microenvironment: Origin to execution.

  2022cites this paper
• Overcoming the limitations of cytokines to improve cancer therapy.

  2022cites this paper
• Tumor promoting roles of IL-10, TGF-β, IL-4, and IL-35: Its implications in cancer immunotherapy

  2022cites this paper
• New Developments in T Cell Immunometabolism and Implications for Cancer Immunotherapy

  2022cites this paper
• CD4+ T-cell-derived IL-10 promotes CNS inflammation in mice by sustaining effector T cell survival.

  2022cites this paper
• Epigenetic Modifications in Tumor-Associated Macrophages: A New Perspective for an Old Foe

  2022cites this paper
• Facts and hopes for immunotherapy in renal cell carcinoma.

  2022cites this paper